eFFECTOR Therapeutics Inc... (EFTR)

0.00

-0.00 (-100.00%)

At close: Feb 27, 2025, 3:56 PM

0.00

0.00%

Pre-market: Jan 16, 2025, 10:01 AM EST

eFFECTOR Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-35.81M	-22.66M	15.8M	14.21M	-29.74M
Depreciation & Amortization	111K	53K	24K	160K	307K
Stock-Based Compensation	4.59M	5.33M	8.66M	499K	646K
Other Working Capital	830K	1.72M	-393K	-573K	1.8M
Other Non-Cash Items	-130K	-11.3M	-48.59M	122K	2.1M
Deferred Income Tax	n/a	n/a	-539K	-333K	-1.99M
Change in Working Capital	1.69M	2.68M	-238K	-824K	1.07M
Operating Cash Flow	-29.55M	-25.9M	-24.89M	13.84M	-27.6M
Capital Expenditures	-97K	-192K	-42K	-154K	-4K
Acquisitions	n/a	17.67M	607K	n/a	88K
Purchase of Investments	-17.17M	-52.42M	n/a	n/a	n/a
Sales Maturities Of Investments	31.75M	34.75M	n/a	n/a	n/a
Other Investing Acitivies	n/a	-17.67M	607K	n/a	88K
Investing Cash Flow	14.48M	-17.86M	565K	-154K	84K
Debt Repayment	n/a	n/a	5.89M	-2M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-86K
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	56K	-34K	52.91M	108K	20.24M
Financial Cash Flow	21.23M	2.77M	58.81M	-1.89M	20.24M
Net Cash Flow	6.17M	-40.99M	34.49M	11.79M	3.43M
Free Cash Flow	-29.65M	-26.09M	-24.93M	13.68M	-27.6M